More than 500,000 Britons are believed to be using weight loss drugs but a waning appetite is not all they report – there’s also a lack of desire to drink alcohol ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...

Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.

A newly discovered natural peptide called BRP shows promising weight loss effects without the side effects of Ozempic. Learn how this non-incretin hormone could revolutionize obesity treatment.

Experts explain if Ozempic causes hair loss, and how the medication may indirectly lead to weight loss-related hair loss due ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.

Discover how to get Mounjaro for weight loss, its benefits, side effects, pricing, and how Mitolyn can enhance your results.

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

Type 2 diabetes mellitus (T2DM) is a prevalent yet complex metabolic disorder that has shown a rising incidence over the past few decades. Recent research has identified flavonoids as compounds ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's ...